Page 4 - genveon oznur

L. Elmer et al. / Journal of the Neurological Sciences 248 (2006) 78–83 81

clinicians as they consider therapeutic options among the University of Alberta, Edmonton; Charles Adler, MD, PhD,
many available agents. Marlene Lind, RN: Mayo Clinic Scottsdale, Scottsdale;
Peter LeWitt, MD, Maryan Deangelis, RN: Clinical
Neuroscience Center, Southfield; Mark Forrest Gordon,
Acknowledgment MD: Long Island Jewish Medical Center, New Hyde Park;
Cathi-Ann Thomas, RN, MS: Boston University School of
The authors wish to acknowledge the investigators and Medicine, Boston.
coordinators of the primary TEMPO and PRESTO studies Presto
[1,2]. This study was supported by Teva Pharmaceutical Participating Investigators and Coordinators: Lawrence
Industries, Ltd. (Netanya, Israel), H. Lundbeck A/S Elmer, MD PhD, Kathy Davis: Medical University of Ohio,
(Copenhagen, Denmark), and in the United States by Teva Toledo; Enrico Fazzini, MD, Linda Chin, RN: New York
Neuroscience, Inc. (Kansas City, Mo), now in partnership University Medical Center, New York; Burton Scott, MD:
with Eisai Inc. (Teaneck, NJ). Duke University Medical Center, Durham; Amy Colcher,
MD, Sue Reichwein, CCRC: University of Pennsylvania,
Philadelphia; Robert Hauser, MD, Lisa Gauger, BA:
Appendix A University of South Florida, Tampa; Maureen Leehey,
MD, Teresa Derian, RN: University of Colorado Health
The following members of the Parkinson Study Group Sciences Center, Denver; William Ondo, MD: Baylor
participated in this study and authored this report: College of Medicine, Houston; Peter Lewitt, MD: Clinical
Tempo Neuroscience Center, Southfield; Madaline Harrison, MD,
Participating Investigators and Coordinators: Mark F. Elke Rost-Ruffner, RN, BSN: University of Virginia,
Lew, MD, Connie Kawai, RN, BSN, CCRC: University of Charlottesville; Brad Racette, MD, Patricia Deppen: Wash-
Southern California, Los Angeles; Howard Hurtig, MD, ington University, St Louis; Karen Frei, MD, Nancy Luong,
Mary Lloyd, RN, PhD: University of Pennsylvania, BS: The Parkinson_s & Movement Disorder Institute,
Philadelphia; Robert Hauser, MD, Lisa Gauger, BA: Fountain Valley; Rajesh Pahwa, MD: University of Kansas
University of South Florida, Tampa; Lawrence Golbe, Medical Center, Kansas City; Mark F. Lew, MD, Connie
MD: UMDNJ Robert Wood Johnson Medical School, Kawai, RN, BSN, CCRC: University of Southern Califor-
New Brunswick; Joanne Wojcieszek, MD, Joann Belden, nia, Los Angeles; Danna Jennings, MD, Karen Caplan,
RN: Indiana University School of Medicine, Indianapolis; MSW: Institute for Neurodegenerative Disorders, New
Andrew Feigin, MD, Barbara Shannon, RN: North Shore- Haven; Peter Novak, MD, Cathi-Ann Thomas, RN: Boston
LIJ Health System, Manhasset; William Ondo, MD, University, Boston; Sylvain Chouinard, MD, Valerie Sol-
Christine Hunter, RN: Baylor College of Medicine, Hous- and, MD: Hotel-Dieu Hospital-CHUM, Montreal; Samer
ton; Vincent Calabrese, MD: Medical College of Virginia, Tabbal, MD, Ergun Uc, MD, Jana Patterson, RN: University
Richmond; Paul Atchison, MD: University of Alabama at of Arkansas for Medical Sciences, Little Rock; Hubert
Birmingham, Birmingham; Frederick Marshall, MD, Debra Fernandez, MD: Brown University, Pawtucket; John M.
Berry, MSN, NP, Irenita Gardiner, RN: University of Bertoni, MD, Larisa Skrypnik, BS: Creighton University,
Rochester, Rochester; Tilak Mendis, MD, Neila Mendis: Omaha; Michel Panisset, MD: McGill Centre for Studies in
Parkinson’s Clinic, Ottawa; Rajesh Pahwa, MD: University Aging, Verdun, Quebec, Canada; Eric Molho, MD: Albany
of Kansas Medical Center, Kansas City; Eric Molho, MD, Medical College, Albany; Arif Dalvi, MD: University of
Sharon Evans, LPN: Albany Medical College, Albany; Lisa Cincinnati/Cincinnati Children_s Hospital, Ohio; Christo-
Shulman, MD: University of Miami, Miami; Ali Rajput, pher Goetz, MD, Kimberly Janko, RN, BSN: Rush
MD, Marianne Ewanishin, RN: Saskatoon District Health University Medical Center, Chicago; Tilak Mendis, MD:
Board Royal University Hospital, Saskatoon; Mark Stacy, Ottawa Hospital Civic Site, Ottawa; Richard Camicioli,
MD: Barrow Neurological Institute, Phoenix; John Bertoni, MD, Pamela King, RN, BSN: University of Alberta,
MD, Carolyn Peterson, RN: Creighton University, Omaha; Edmonton, Alberta; Joanne Wojcieszek, MD, Joann Belden,
Paul Tuite, MD: University of Minnesota/Minnesota VA RN: Indiana University School of Medicine, Indianapolis;
Medical Center, Minneapolis; Kathleen Shannon, MD, Rajeev Kumar, MD: Colorado Neurological Institute,
Jeana Jaglin, RN CCRC: Rush University Medical Center, Englewood; David Margolin, MD, PhD: Margolin Brain
Chicago; Caroline Tanner, MD, Tracy Stewart, RN: The Institute, Fresno; Paul Gordon, MD, Martha Meister, RN:
Parkinson’s Institute, Sunnyvale; Kenneth Marek, MD: University of New Mexico, Albuquerque; Frederick Mar-
Institute for Neurodegenerative Disorders, New Haven; shall, MD, Debra Berry, MSN, NP: University of Rochester,
Michael J. Aminoff, MD, Glenna Dowling, RN, PhD: Rochester; David Rottenberg, MD, Joy Hansen, RN:
University of California San Francisco, San Francisco; Un University of Minnesota/Minneapolis VA Medical Center,
Jung Kang, MD: University of Chicago, Chicago; Kapil Minneapolis, Minnesota; Mark Forrest Gordon, MD: Long
Sethi, MD: Medical College of Georgia, Augusta; Wayne Island Jewish Medical Center, Long Island; Mohamed
Martin, MD, Pamela King, RN, Germaine McInnes, RN: Hassan, MD, Patricia Keltonic, RN: University of Con-